Adam Dublin is a seasoned entrepreneur and senior executive with extensive strategy, business development, and operating expertise in healthcare information and technology. He is responsible for developing Forian’s strategy, data acquisition, partnership development and acquisitions, and he has over 30 years of experience in creating innovative businesses. Prior to the sale of the company to KKR for $2.8 billion, he was on the executive leadership team of WebMD as Senior Vice President, Strategy and Analytics. In that role, he was responsible for developing the company’s marketing science platform, including the development of one of the world’s largest healthcare customer databases, linking patient, consumer demographic and online behavioral data in a HIPAA-compliant manner.
Previously, he was Vice President, Strategy and Corporate Development for IMS Health, the world’s largest healthcare information provider (now IQVIA). He came to IMS Health from SDI, where he was the Chief Strategy Officer. SDI was the recognized leader in longitudinal patient data prior to its acquisition by IMS health in 2011 for $340 million. His track record at SDI included multiple strategic acquisitions that enabled the company to continuously drive growth, resulting in the company eventually becoming the third-largest pharmaceutical informatics organization in the US. At SDI, he patented encryption and de-identification technologies that enabled the linkage of patient databases to a HIPAA-compliant standard, creating one of the first and largest Real World Evidence (RWE) platforms supporting health economics and outcomes research. Prior to SDI, Adam was Senior Vice President Corporate Key Accounts for NDCHealth, one of the nation’s largest healthcare IT companies and the nation’s second-largest pharmaceutical informatics organization. He had P&L for NDC’s wholesale data businesses, commercializing data assets to multiple industries and creating new lines of business in payer analytics, benefits administration, underwriting, and consumer analytics. Adam was instrumental in the sale of the company’s pharmaceutical informatics business to Wolters Kluwer for $352 million. Prior to NDCHealth, he was one of the founders of Health Market Science, a provider data solutions business specializing in data mining and probabilistic matching technologies that was sold to Edison Ventures for $65 million, and now owned by LexisNexis.
Adam received a BA from the University of Iowa and an MA from Northwestern University.
December, 2020 - present
Co-founder & Chief Strategy Officer at CABRA Sports
Co-founder & Chief Strategy Officer (cso) at NetFoundry
Co-founder, Chief Strategy Officer And Chief Operating Officer at Stora
Co-Founder & Chief Strategy Officer at Paddle
Co-Founder & Chief Strategy Officer at Ayar Labs
Access the worlds's biggest network of public org charts
Learn more